(NHTC) Natural Health Trend - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US63888P4063

Wellness, Beauty, Lifestyle, Home, Health

NHTC EPS (Earnings per Share)

EPS (Earnings per Share) of NHTC over the last years for every Quarter: "2020-03": -0.054659925593819, "2020-06": 0.0029761904761905, "2020-09": 0.055584733893557, "2020-12": 0.065388655462185, "2021-03": 0.013392857142857, "2021-06": 0.020045518207283, "2021-09": 0.041228991596639, "2021-12": 0.0203081232493, "2022-03": -0.0093300159943131, "2022-06": 0.016018907563025, "2022-09": 0.004114505821588, "2022-12": 0.016458023286352, "2023-03": 0.022488624431222, "2023-06": -0.019156752974108, "2023-09": 0.015016588091496, "2023-12": 0.031236366809179, "2024-03": 0.016384870141189, "2024-06": 0.015065749368632, "2024-09": 0.0030461270670148, "2024-12": 0.015323001915375, "2025-03": 0.010617004612305, "2025-06": 0.0013046881795251,

NHTC Revenue

Revenue of NHTC over the last years for every Quarter: 2020-03: 14.948, 2020-06: 16.404, 2020-09: 14.124, 2020-12: 16.595, 2021-03: 13.469, 2021-06: 16.152, 2021-09: 14.276, 2021-12: 16.108, 2022-03: 11.546, 2022-06: 13.36, 2022-09: 11.716, 2022-12: 12.512, 2023-03: 11.861, 2023-06: 10.511, 2023-09: 10.615, 2023-12: 10.937, 2024-03: 10.951, 2024-06: 10.475, 2024-09: 10.691, 2024-12: 10.846, 2025-03: 10.737, 2025-06: 9.813,

Description: NHTC Natural Health Trend

Natural Health Trends Corp. (NHTC) is a direct-selling and e-commerce company that operates under the NHT Global brand, offering a diverse range of personal care, wellness, and lifestyle products. The companys product portfolio includes a variety of wellness supplements, such as dietary and nutritional supplements, vitamins, and minerals, as well as herbal products. Additionally, NHTC provides beauty products, including age-defying and hydrating skincare products, and lifestyle products like weight management and energy enhancing supplements.

The companys product offerings also extend to home appliances, daily care products, and at-home testing kits for measuring various biomarkers related to overall well-being. NHTC sells its products directly to consumers through various channels, including e-commerce platforms, in multiple regions worldwide, including North America, Asia, and Europe. With a history dating back to 1988, the company has established a significant presence in the global market, leveraging its direct-selling and e-commerce capabilities to reach a broad customer base.

From a market perspective, NHTC operates within the personal care products industry, a sector characterized by a growing demand for wellness and health-related products. The companys business model, which combines direct selling with e-commerce, allows it to maintain a competitive edge in a rapidly evolving market landscape. With a market capitalization of $57.57 million, NHTCs stock is closely watched by investors seeking exposure to the personal care and wellness industry.

Analyzing the and available, we can observe that NHTCs stock price is currently at $4.60, below its short-term and long-term moving averages, indicating a potential downtrend. The Average True Range (ATR) of 0.24 suggests a relatively moderate level of price volatility. Considering the , the companys high P/E ratio of 125.00 may indicate overvaluation, while the low Return on Equity (RoE) of 1.48% raises concerns about the companys profitability.

Based on the available data, a forecast for NHTC could be constructed by analyzing the intersection of technical and fundamental indicators. Given the current downtrend and high P/E ratio, a cautious outlook is warranted. However, if NHTC can demonstrate improved profitability and effectively manage its product offerings and distribution channels, there may be potential for a turnaround. A potential price target could be around $5.50, representing a 20% increase from current levels, contingent upon the companys ability to address its profitability concerns and capitalize on the growing demand for wellness products.

NHTC Stock Overview

Market Cap in USD 50m
Sub-Industry Personal Care Products
IPO / Inception 1995-06-21

NHTC Stock Ratings

Growth Rating 2.71%
Fundamental 25.7%
Dividend Rating 65.0%
Return 12m vs S&P 500 -37.2%
Analyst Rating -

NHTC Dividends

Dividend Yield 12m 17.86%
Yield on Cost 5y 29.20%
Annual Growth 5y 0.00%
Payout Consistency 84.0%
Payout Ratio 26.5%

NHTC Growth Ratios

Growth Correlation 3m -15%
Growth Correlation 12m -56.4%
Growth Correlation 5y 60.9%
CAGR 5y 9.77%
CAGR/Max DD 5y 0.18
Sharpe Ratio 12m -0.11
Alpha -33.33
Beta 0.223
Volatility 26.32%
Current Volume 3.9k
Average Volume 20d 28.2k
Stop Loss 4.1 (-5.7%)
Signal -3.42

Piotroski VR‑10 (Strict, 0-10) 1.5

Net Income (348.0k TTM) > 0 and > 6% of Revenue (6% = 2.53m TTM)
FCFTA -0.08 (>2.0%) and ΔFCFTA -0.55pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 61.57% (prev 80.90%; Δ -19.33pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -0.12 (>3.0%) and CFO -5.50m <= Net Income 348.0k (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 2.73 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (11.5m) change vs 12m ago 0.12% (target <= -2.0% for YES)
Gross Margin 73.97% (prev 74.04%; Δ -0.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 78.92% (prev 69.89%; Δ 9.03pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM)

Altman Z'' -0.68

(A) 0.57 = (Total Current Assets 40.9m - Total Current Liabilities 14.9m) / Total Assets 45.2m
(B) -0.68 = Retained Earnings (Balance) -30.8m / Total Assets 45.2m
(C) -0.03 = EBIT TTM -1.37m / Avg Total Assets 53.3m
(D) -1.95 = Book Value of Equity -31.7m / Total Liabilities 16.3m
Total Rating: -0.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 25.74

1. Piotroski 1.50pt = -3.50
2. FCF Yield -18.41% = -5.0
3. FCF Margin -8.14% = -3.05
4. Debt/Equity 0.08 = 2.50
5. Debt/Ebitda -1.93 = -2.50
6. ROIC - WACC -4.30% = -5.37
7. RoE 1.09% = 0.09
8. Rev. Trend -75.81% = -3.79
9. Rev. CAGR -6.24% = -1.04
10. EPS Trend -3.71% = -0.09
11. EPS CAGR -34.14% = -2.50

What is the price of NHTC shares?

As of August 29, 2025, the stock is trading at USD 4.35 with a total of 3,927 shares traded.
Over the past week, the price has changed by +0.69%, over one month by -2.98%, over three months by -7.11% and over the past year by -26.06%.

Is Natural Health Trend a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Natural Health Trend (NASDAQ:NHTC) is currently (August 2025) a stock to sell. It has a ValueRay Fundamental Rating of 25.74 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NHTC is around 4.78 USD . This means that NHTC is currently overvalued and has a potential downside of 9.89%.

Is NHTC a buy, sell or hold?

Natural Health Trend has no consensus analysts rating.

What are the forecasts/targets for the NHTC price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 5.3 20.7%

Last update: 2025-08-28 04:46

NHTC Fundamental Data Overview

Market Cap USD = 50.4m (50.4m USD * 1.0 USD.USD)
CCE Cash And Equivalents = 34.2m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 146.0
P/S = 1.1982
P/B = 1.7475
Beta = 0.588
Revenue TTM = 42.1m USD
EBIT TTM = -1.37m USD
EBITDA TTM = -1.25m USD
Long Term Debt = 1.36m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.06m USD (from shortTermDebt, last quarter)
Debt = 2.42m USD (Calculated: Short Term 1.06m + Long Term 1.36m)
Net Debt = -8.29m USD (from netDebt column, last quarter)
Enterprise Value = 18.6m USD (50.4m + Debt 2.42m - CCE 34.2m)
Interest Coverage Ratio = unknown (Ebit TTM -1.37m / Interest Expense TTM 0.0)
FCF Yield = -18.41% (FCF TTM -3.42m / Enterprise Value 18.6m)
FCF Margin = -8.14% (FCF TTM -3.42m / Revenue TTM 42.1m)
Net Margin = 0.83% (Net Income TTM 348.0k / Revenue TTM 42.1m)
Gross Margin = 73.97% ((Revenue TTM 42.1m - Cost of Revenue TTM 11.0m) / Revenue TTM)
Tobins Q-Ratio = -0.59 (set to none) (Enterprise Value 18.6m / Book Value Of Equity -31.7m)
Interest Expense / Debt = 88.88% (Interest Expense 2.15m / Debt 2.42m)
Taxrate = 7.74% (from yearly Income Tax Expense: 48.0k / 620.0k)
NOPAT = -1.37m (EBIT -1.37m, no tax applied on loss)
Current Ratio = 2.73 (Total Current Assets 40.9m / Total Current Liabilities 14.9m)
Debt / Equity = 0.08 (Debt 2.42m / last Quarter total Stockholder Equity 28.9m)
Debt / EBITDA = -1.93 (Net Debt -8.29m / EBITDA -1.25m)
Debt / FCF = -0.71 (Debt 2.42m / FCF TTM -3.42m)
Total Stockholder Equity = 32.0m (last 4 quarters mean)
RoA = 0.77% (Net Income 348.0k, Total Assets 45.2m )
RoE = 1.09% (Net Income TTM 348.0k / Total Stockholder Equity 32.0m)
RoCE = -4.12% (Ebit -1.37m / (Equity 32.0m + L.T.Debt 1.36m))
RoIC = -4.30% (NOPAT -1.37m / Invested Capital 32.0m)
WACC = unknown (E(50.4m)/V(52.8m) * Re(6.84%)) + (D(2.42m)/V(52.8m) * Rd(none%) * (1-Tc(0.08)))
Shares Correlation 5-Years: 90.0 | Cagr: 0.16%
Discount Rate = 6.84% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -3.42m)
Revenue Correlation: -75.81 | Revenue CAGR: -6.24%
Rev Growth-of-Growth: 4.91
EPS Correlation: -3.71 | EPS CAGR: -34.14%
EPS Growth-of-Growth: -140.1

Additional Sources for NHTC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle